These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33859370)

  • 1. Multimodal, label-free fluorescence and Raman imaging of amyloid deposits in snap-frozen Alzheimer's disease human brain tissue.
    Lochocki B; Boon BDC; Verheul SR; Zada L; Hoozemans JJM; Ariese F; de Boer JF
    Commun Biol; 2021 Apr; 4(1):474. PubMed ID: 33859370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Label-free vibrational imaging of different Aβ plaque types in Alzheimer's disease reveals sequential events in plaque development.
    Röhr D; Boon BDC; Schuler M; Kremer K; Hoozemans JJM; Bouwman FH; El-Mashtoly SF; Nabers A; Großerueschkamp F; Rozemuller AJM; Gerwert K
    Acta Neuropathol Commun; 2020 Dec; 8(1):222. PubMed ID: 33308303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-free imaging of amyloid plaques in Alzheimer's disease with stimulated Raman scattering microscopy.
    Ji M; Arbel M; Zhang L; Freudiger CW; Hou SS; Lin D; Yang X; Bacskai BJ; Xie XS
    Sci Adv; 2018 Nov; 4(11):eaat7715. PubMed ID: 30456301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The search for a unique Raman signature of amyloid-beta plaques in human brain tissue from Alzheimer's disease patients.
    Lochocki B; Morrema THJ; Ariese F; Hoozemans JJM; de Boer JF
    Analyst; 2020 Mar; 145(5):1724-1736. PubMed ID: 31907497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
    Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
    Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperspectral Raman imaging of neuritic plaques and neurofibrillary tangles in brain tissue from Alzheimer's disease patients.
    Michael R; Lenferink A; Vrensen GFJM; Gelpi E; Barraquer RI; Otto C
    Sci Rep; 2017 Nov; 7(1):15603. PubMed ID: 29142266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.
    Styren SD; Hamilton RL; Styren GC; Klunk WE
    J Histochem Cytochem; 2000 Sep; 48(9):1223-32. PubMed ID: 10950879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonlinear and vibrational microscopy for label-free characterization of amyloid-β plaques in Alzheimer's disease model.
    Cunha R; Lafeta L; Fonseca EA; Barbosa A; Romano-Silva MA; Vieira R; Jorio A; Malard LM
    Analyst; 2021 May; 146(9):2945-2954. PubMed ID: 33949418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plaque-associated lipids in Alzheimer's diseased brain tissue visualized by nonlinear microscopy.
    Kiskis J; Fink H; Nyberg L; Thyr J; Li JY; Enejder A
    Sci Rep; 2015 Aug; 5():13489. PubMed ID: 26311128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.
    Dickson TC; Vickers JC
    Neuroscience; 2001; 105(1):99-107. PubMed ID: 11483304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer's disease.
    Boon BDC; Bulk M; Jonker AJ; Morrema THJ; van den Berg E; Popovic M; Walter J; Kumar S; van der Lee SJ; Holstege H; Zhu X; Van Nostrand WE; Natté R; van der Weerd L; Bouwman FH; van de Berg WDJ; Rozemuller AJM; Hoozemans JJM
    Acta Neuropathol; 2020 Dec; 140(6):811-830. PubMed ID: 32926214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrillar amyloid-beta affects neurofibrillary changes but only in neurons already involved in neurofibrillary degeneration.
    Wegiel J; Bobinski M; Tarnawski M; Dziewiatkowski J; Popovitch E; Miller DC; Wisniewski T; Golomb J; de Leon MJ; Reisberg B
    Acta Neuropathol; 2001 Jun; 101(6):585-90. PubMed ID: 11515787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of methods to use Congo-red stain to simultaneously visualize amyloid plaques and tangles in human and rodent brain tissue sections.
    Sarkar S; Raymick J; Cuevas E; Rosas-Hernandez H; Hanig J
    Metab Brain Dis; 2020 Dec; 35(8):1371-1383. PubMed ID: 32852699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.
    Choi SR; Schneider JA; Bennett DA; Beach TG; Bedell BJ; Zehntner SP; Krautkramer MJ; Kung HF; Skovronsky DM; Hefti F; Clark CM
    Alzheimer Dis Assoc Disord; 2012; 26(1):8-16. PubMed ID: 22354138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer's disease brain.
    Harada R; Okamura N; Furumoto S; Yoshikawa T; Arai H; Yanai K; Kudo Y
    Mol Imaging Biol; 2014 Feb; 16(1):19-27. PubMed ID: 23868612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer's amyloid pathology.
    Stepanchuk AA; Morgan ML; Joseph JT; Stys PK
    Acta Neuropathol Commun; 2022 Oct; 10(1):153. PubMed ID: 36307888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
    Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
    Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
    Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
    J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.
    Parent MJ; Zimmer ER; Shin M; Kang MS; Fonov VS; Mathieu A; Aliaga A; Kostikov A; Do Carmo S; Dea D; Poirier J; Soucy JP; Gauthier S; Cuello AC; Rosa-Neto P
    J Neurosci; 2017 Dec; 37(50):12263-12271. PubMed ID: 29097597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.